Gene · 51744
Papers3,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunological Characteristics of Hepatic Dendritic Cells in Patients and Mouse Model with Liver Echinococcus multilocularis Infection. | Trop Med Infect Dis | 2024 | 38787028 | PubTator, text mining | PubMed |
| BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia. | JCI Insight | 2024 | 38775157 | PubTator, text mining | PubMed |
| Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population. | Front Immunol | 2024 | 38742104 | PubTator, text mining | PubMed |
| Ex vivo sensitivity to broadly neutralizing antibodies and anti-CD4 antibody UB-421 of infectious viral isolates from people living with multidrug-resistant HIV. | EBioMedicine | 2024 | 38728839 | PubTator, text mining | PubMed |
| Distinct roles of CD244 expression in cancer diagnosis and prognosis: A pan-cancer analysis. | Heliyon | 2024 | 38633624 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets. | J Clin Med | 2024 | 38592036 | PubTator, text mining | PubMed |
| NK cell receptor profiling of endometrial and decidual NK cells reveals pregnancy-induced adaptations. | Front Immunol | 2024 | 38571943 | PubTator, text mining | PubMed |
| Harnessing innate immune pathways for therapeutic advancement in cancer. | Signal Transduct Target Ther | 2024 | 38523155 | PubTator, text mining | PubMed |
| TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells. | Front Immunol | 2024 | 38510235 | PubTator, text mining | PubMed |
| An Atlas of the Human Nail. | Skinmed | 2024 | 38494614 | PubTator, text mining | PubMed |
| NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer. | Int J Biol Sci | 2024 | 38481806 | PubTator, text mining | PubMed |
| CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer. | Proc Natl Acad Sci U S A | 2024 | 38451948 | PubTator, text mining | PubMed |
| Increased PD-1+ NK Cell Subset in the Older Population. | Int J Gen Med | 2024 | 38435114 | PubTator, text mining | PubMed |
| Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma. | Mol Cancer | 2024 | 38424542 | PubTator, text mining | PubMed |
| Chronic malaria exposure is associated with inhibitory markers on T cells that correlate with atypical memory and marginal zone-like B cells. | Clin Exp Immunol | 2024 | 38387476 | PubTator, text mining | PubMed |
| The immunology of type 1 diabetes. | Nat Rev Immunol | 2024 | 38308004 | PubTator, text mining | PubMed |
| Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseases. | JHEP Rep | 2024 | 38304237 | PubTator, text mining | PubMed |
| T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution. | J Exp Clin Cancer Res | 2024 | 38303018 | PubTator, text mining | PubMed |
| γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression. | Clin Transl Immunology | 2024 | 38299190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51744/papers?page=8